News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
60,905 Results
Type
Article (3863)
Company Profile (10)
Press Release (57032)
Multimedia
Podcasts (8)
Webinars (6)
Section
Business (22004)
Career Advice (71)
Deals (3829)
Drug Delivery (13)
Drug Development (4455)
Employer Resources (13)
FDA (941)
Job Trends (1145)
News (30185)
Policy (1422)
Tag
Academia (268)
Accelerated approval (1)
Allergies (7)
Alliances (5328)
ALS (14)
Alzheimer's disease (144)
Antibody-drug conjugate (ADC) (19)
Approvals (955)
Artificial intelligence (88)
Autoimmune disease (18)
Automation (3)
Bankruptcy (32)
Best Places to Work (819)
BIOSECURE Act (2)
Biosimilars (22)
Biotechnology (13)
Bladder cancer (10)
Brain cancer (4)
Breast cancer (28)
Cancer (297)
Cardiovascular disease (45)
Career advice (65)
Career pathing (3)
CAR-T (26)
Cell therapy (71)
Clinical research (3639)
Collaboration (202)
Compensation (8)
Complete response letters (4)
COVID-19 (163)
CRISPR (10)
C-suite (151)
Cystic fibrosis (15)
Data (335)
Denatured (2)
Depression (8)
Diabetes (41)
Diagnostics (649)
Digital health (8)
Diversity (4)
Diversity, equity & inclusion (2)
Drug discovery (38)
Drug pricing (14)
Duchenne muscular dystrophy (7)
Earnings (4712)
Editorial (7)
Employer resources (11)
Events (5778)
Executive appointments (180)
FDA (1133)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (678)
Gene editing (22)
Generative AI (9)
Gene therapy (55)
GLP-1 (79)
Government (152)
Guidances (30)
Healthcare (1335)
HIV (4)
Huntington's disease (1)
IgA nephropathy (5)
Immunology and inflammation (28)
Immuno-oncology (4)
Indications (6)
Infectious disease (180)
Inflammatory bowel disease (19)
Inflation Reduction Act (4)
Influenza (4)
Intellectual property (19)
Interviews (5)
IPO (1790)
IRA (8)
Job creations (323)
Job search strategy (61)
JPM (9)
Labor market (18)
Layoffs (46)
Leadership (3)
Legal (280)
Liver cancer (5)
Longevity (2)
Lung cancer (38)
Lymphoma (19)
Machine learning (7)
Management (5)
Manufacturing (66)
MASH (9)
Medical device (1342)
Medtech (1352)
Mergers & acquisitions (2155)
Metabolic disorders (114)
Multiple sclerosis (6)
NASH (1)
Neurodegenerative disease (35)
Neuropsychiatric disorders (7)
Neuroscience (232)
Neurotech (1)
NextGen: Class of 2026 (987)
Non-profit (326)
Now hiring (3)
Obesity (62)
Opinion (53)
Ovarian cancer (7)
Pain (12)
Pancreatic cancer (4)
Parkinson's disease (18)
Partnered (7)
Patents (23)
Patient recruitment (51)
Peanut (5)
People (9147)
Pharmaceutical (4)
Phase 1 (1182)
Phase 2 (1650)
Phase 3 (1074)
Pipeline (313)
Policy (19)
Postmarket research (127)
Preclinical (641)
Press Release (7)
Prostate cancer (18)
Psychedelics (4)
Radiopharmaceuticals (34)
Rare diseases (69)
Real estate (595)
Recruiting (5)
Regulatory (1197)
Reports (4)
Research institute (204)
Resumes & cover letters (9)
Rett syndrome (2)
RNA editing (3)
Schizophrenia (4)
Series A (184)
Series B (137)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (2208)
Supply chain (6)
Tariffs (4)
The Weekly (6)
Vaccines (33)
Venture capital (79)
Weight loss (32)
Women's health (7)
Date
Today (3)
Last 7 days (39)
Last 30 days (194)
Last 365 days (2451)
2026 (228)
2025 (2547)
2024 (3074)
2023 (3242)
2022 (5699)
2021 (5106)
2020 (4885)
2019 (4479)
2018 (3598)
2017 (3155)
2016 (2637)
2015 (3022)
2014 (2202)
2013 (1818)
2012 (1920)
2011 (2140)
2010 (2234)
Location
Africa (73)
Alabama (7)
Alaska (2)
Arizona (17)
Arkansas (5)
Asia (4224)
Australia (514)
California (965)
Canada (747)
China (99)
Colorado (24)
Connecticut (36)
Delaware (11)
Europe (8824)
Florida (66)
Georgia (31)
Hawaii (2)
Idaho (5)
Illinois (57)
India (16)
Indiana (30)
Iowa (2)
Japan (43)
Kansas (7)
Kentucky (5)
Louisiana (6)
Maine (6)
Maryland (65)
Massachusetts (531)
Michigan (17)
Minnesota (30)
Mississippi (1)
Missouri (17)
Montana (1)
Nebraska (1)
Nevada (14)
New Hampshire (7)
New Jersey (162)
New Mexico (4)
New York (179)
North Carolina (109)
Northern California (453)
Ohio (37)
Oklahoma (4)
Oregon (4)
Pennsylvania (109)
Puerto Rico (3)
Rhode Island (6)
South America (104)
South Carolina (7)
Southern California (358)
Tennessee (11)
Texas (89)
United States (2661)
Utah (33)
Virginia (17)
Washington D.C. (3)
Washington State (58)
West Virginia (1)
Wisconsin (12)
60,905 Results for "atlas venture".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stealth Third Rock Ventures Backed Company Selects Parse Biosciences GigaLab to Build Largest TCR Atlas for Common Autoimmune Disease
November 13, 2025
·
2 min read
Press Releases
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
January 20, 2026
·
3 min read
Press Releases
Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV
January 7, 2026
·
2 min read
Press Releases
Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell Profiles for Large-Scale Perturbation Atlas
December 12, 2025
·
4 min read
Press Releases
T-knife Therapeutics Files Clinical Trial Application for Phase 1 ATLAS Trial for TK-6302, a Supercharged PRAME-targeted T Cell Receptor Therapy
November 18, 2025
·
3 min read
Press Releases
RAD Increases Ownership in Radiopharm Ventures to 87.5%
January 12, 2026
·
3 min read
Venture capital
Sanofi Fattens Venture Unit With $625M Infusion for Rare Disease, Neuro Innovation
Sanofi Ventures, which now has $1.4 billion in total assets, will focus its investment efforts on early players working in immunology, rare diseases, neurology and vaccines.
September 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Helmholtz Munich and Parse Biosciences GigaLab Generate World’s Largest Human Lung Tissue Perturbation Atlas
September 16, 2025
·
3 min read
Press Releases
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan
January 5, 2026
·
2 min read
Press Releases
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
February 5, 2026
·
5 min read
1 of 6,091
Next
